T. Rowe Price Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

T. Rowe Price Investment Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-31	Closed	-$2K	–	855
2025 Q4	$2K	Buy	31 +10	+48%	+$612	﹤0.01%	877
2025 Q3	$2K	Buy	+21	New	+$1.46K	﹤0.01%	859

Other funds holding PBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Investment Management's PBH Position: Q1 2026 in Review

T. Rowe Price Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 31 shares — an estimated $2K sold.

T. Rowe Price Investment Management first reported a position in PBH in Q3 2025 and held it in 2 quarters. The position peaked at $2K in Q4 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

T. Rowe Price Investment Management reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
T. Rowe Price Investment Management sold 31 Prestige Consumer Healthcare shares in Q1 2026, an estimated $2K.
T. Rowe Price Investment Management first reported a position in Prestige Consumer Healthcare in Q3 2025 and held it in 2 quarters.
T. Rowe Price Investment Management's Prestige Consumer Healthcare position peaked at $2K in Q4 2025.
355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.